Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Back

IMI
Workshop

W30--Polymicrobial Interactions in CF

Saturday, September 28, 2024
7:45 AM – 9:45 AM ET
Location:156 A-C

Recorded Session

CF respiratory infections are often polymicrobial, which complicates efforts to forecast treatment efficacy and progression of CF disease. This session will describe molecular-, spatial-, and species-level interactions among microbes that define the composition, virulence, and local environment of microbial communities. Presenters will discuss advances in translating CF microbial ecology research into rational diagnostic and therapeutic strategies, with experiences from the incubator to the clinic.

Learning Objectives:

  • Define environmental, therapeutic, and genetic factors that shape the CF respiratory microbiome.
  • Identify microbial interactions associated with changes in respiratory disease states and treatment efficacy.
  • Evaluate model systems and clinical specimens used to study polymicrobial communities in CF airways.

Presentations:

  • 7:45 AM – 9:45 AM ET
    W30.1- Widespread fungal-bacterial competition for magnesium enhances antibiotic resistance

    Speaker: Yu-Ying P. Hsieh (she/her/hers) – Fred Hutchinson Cancer Center

  • 7:45 AM – 9:45 AM ET
    W30.2- Chronic Staphylococcus aureus infection alters the lung metabolome to promote co-colonization with Pseudomonas aeruginosa in the cystic fibrosis rat.

    Speaker: Kendall M. Shaffer (she/her/hers) – University of Alabama at Birmingham

  • 7:45 AM – 9:45 AM ET
    W30.3- Spatio-temporal association of Pseudomonas aeruginosa and Staphylococcus aureus in CF sputum during pulmonary exacerbation

    Speaker: Amanda J. Morris, PhD – The Hospital for Sick Children

  • 7:45 AM – 9:45 AM ET
    W30.4- Microenvironmental effects of a non-antibiotic therapy for a chronic airway disease modulate the virulence of its principal pathogen

    Speaker: Cely Teresa Gonzalez, PhD (she/her/hers) – Michigan State University

  • 7:45 AM – 9:45 AM ET
    W30.5- Microbial and metabolic ecology of expectorated sputum from people with cystic fibrosis from the STOP2 study

    Speaker: Katrine L. Whiteson, PhD (she/her/hers) – University of California Irvine